Companies
Genoscope
the national sequencing centre uses nanopores for real-time ocean and soil metagenomic surveillance (e.g. nanoMDBG metagenome assembly).
- Country
- France
Coverage
| CN | EU | US | |
|---|---|---|---|
| bioinformatics-omics | ✓ | ✓ | ✓ |
| ecosystem-restoration | ✓ | ✓ | ✓ |
Regulatorsfdanmpausda-aphisefsamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Public funding through CEA, France Génomique, ANR, and EU programs, including a €41.3M grant for the ATLASea program (2024) | hal-hceres.archives-ouvertes.fr · pmc.ncbi.nlm.nih.gov · cea.fr · france-genomique.org · genopole.com · scoop.it |
| Capacity | Equipped with multiple high-throughput sequencers including Illumina (NovaSeq, HiSeq, MiSeq), Oxford Nanopore (MinION, GridION, PromethION), and MGI (DNBSEQ-G400) platforms, supported by a 1700-core computing cluster and 1.5 PB storage, plus access to CEA computing resources | france-genomique.org · genopole.com · genoscope.cns.fr |
| Certification | Laboratory Information Management System (LIMS) with automated primary analysis pipelines and integrated QC systems | france-genomique.org · genoscope.cns.fr |
| Production site | Located in the Genopole biocluster at Evry-Courcouronnes, France | hal-hceres.archives-ouvertes.fr · cea.fr · france-genomique.org · genopole.com · genoscope.cns.fr |
| Headcount | Approximately 200 employees (CEA/Genoscope-reported estimate) or 37 employees (LinkedIn-reported data) medium confidence | cea.fr |
Independent sources: cea.fr · france-genomique.org · genopole.com · hal-hceres.archives-ouvertes.fr · pmc.ncbi.nlm.nih.gov · scoop.it
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biodiversity genomics | ecosystem-restoration | Low | → |
| Long-read sequencing services | bioinformatics-omics | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.